Evidence map›Paper›PMID 41238099›Full record

ArticleCancer letters2026

A deep learning framework to iDentify prOgnostically releVant cancEr Regions (DOVER) within whole slide histopathology images.

Xiangxue Wang, Yufei Zhou, Cristian Barrera, Yijiang Chen, Bolin Song, Cheng Lu, Kailin Yang, Shlomo Koyfman, James Lewis, Kurt Scahlper and 1 more

Abstract read
In one paragraph

Article in Cancer letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiangxue WangSchool of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing, China.
Yufei ZhouDepartment of Computer and Data Sciences, Case Western Reserve University, Cleveland, OH, USA.
Cristian BarreraWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
Yijiang ChenDepartment of Radiation Oncology, Stanford University, Stanford, CA, USA.
Bolin SongWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
Cheng LuDepartment of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China.
Kailin YangDepartment of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
Shlomo KoyfmanDepartment of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.
James LewisDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ, USA.
Kurt ScahlperDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.
Anant MadabhushiWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA; Atlanta Veterans Administration Medical Center, Atlanta, GA, USA. Electronic address: anantm@emory.edu.

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Ragini Reiney Kudchadkar · 2009 to 2026
$47.5M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas SouthwesternU01CA113913 · NCI · EMORY UNIVERSITY · PI Martin G. Sanda · 2005 to 2026
$16.4M
Pathology CoreU54CA254566 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MADABHUSHI, ANANT · 2020 to 2024
$5.0M
Computer-Assisted Histologic Evaluation of Cardiac Allograft RejectionR01HL151277 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MADABHUSHI, ANANT, MARGULIES, KENNETH BER · 2020 to 2023
$3.2M
Oral Cavity Quantitative Histomorphometric Risk Classifier (OHbIC) in Oral Cavity Squamous Cell Carcinoma (OC-SCC)R01CA249992 · NCI · EMORY UNIVERSITY · PI LEWIS, JAMES, MADABHUSHI, ANANT · 2021 to 2025
$3.2M
Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Prostate cancer risk stratification via computational 3D pathologyR01CA268207 · NCI · UNIVERSITY OF WASHINGTON · PI Jonathan T.C. Liu, Anant Madabhushi · 2022 to 2026
$3.1M
Quantitative Histomorphometric Risk Classifier (QuHbIC) in HPV + Oropharyngeal CarcinomaR01CA220581 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI KOYFMAN, SHLOMO, LEWIS, JAMES · 2018 to 2023
$3.1M
Computerized Histologic Risk Predictor (CHiRP) for Early Stage Lung CancersR01CA216579 · NCI · EMORY UNIVERSITY · PI FU, PINGFU, LLOYD, MARK · 2018 to 2023
$3.1M
Prognostic and Predictive Digital Tissue Image Assay for Prostate CancerR01CA268287 · NCI · EMORY UNIVERSITY · PI GUPTA, SHILPA, LAL, PRITI · 2022 to 2025
$3.0M
MR Fingerprinting and Computerized Decision Support for Prostate CancerR01CA208236 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GULANI, VIKAS, PONSKY, LEE EVAN · 2017 to 2022
$3.0M
BLRD VA I01 BX004121BLRD VA IK6 BX006185CSRD VA I01 CX002622CSRD VA I01 CX002776NCATS NIH HHS UL1 TR002548NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA202752NCI NIH HHS R01 CA208236NCI NIH HHS R01 CA216579NCI NIH HHS R01 CA220581NCI NIH HHS R01 CA249992NCI NIH HHS R01 CA257612NCI NIH HHS R01 CA268207NCI NIH HHS R01 CA268287NCI NIH HHS U01 CA113913NCI NIH HHS U01 CA239055NCI NIH HHS U01 CA248226NCI NIH HHS U01 CA269181NCI NIH HHS U54 CA254566NCRR NIH HHS C06 RR012463NHLBI NIH HHS R01 HL151277NHLBI NIH HHS R01 HL158071NIBIB NIH HHS R43 EB028736
6 · The paper itself

Abstract

The recent advancements in computational pathology focus on extracting valuable prognostic insights from whole-slide images (WSIs). These methods primarily involve deep learning-based or handcrafted feature representations of the disease's morphologic patterns associated with outcomes. However, determining the most prognostic regions within tumors remains challenging due to significant morphologic heterogeneity even within manually annotated tumor areas. In other words, the question is not simply what type of representation is appropriate to predict cancer outcomes, but specifically where to mine those representations. To address this issue, a deep learning framework to identify prognostically relevant (PR) cancer regions (DOVER) within WSIs is presented. DOVER leverages patterns mined from the tissue microarray (TMA) spots with the associated long-term clinical outcomes. The prognostic patterns learned from the individual spots of the TMA (morphologically consistent) are then mapped into larger WSIs to locate PR regions for subsequent feature representation and patient outcome prediction. DOVER improves prognostic prediction in terms of c-index over 20 % (p < 0.05) across 2041 patients (NSCLC: n = 1141; OPSCC: n = 900). Moreover, correlations with quantitative immunofluorescent (QIF) images reveal a diverse CD8

Indexed as

Deep LearningNeoplasmsHumansPrognosisTissue Array AnalysisComputational pathologyPrognostically relevancePrognostic prediction

Identifiers

PMID41238099
PMCPMC12640559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.